Life-Saving protein trial for critical Post-Surgery patients
NCT ID NCT07212582
Summary
This study aims to see if adding a protein called human albumin to standard intensive care helps more patients survive a life-threatening condition called surgical septic shock. About 304 adult patients in a surgical ICU will be randomly assigned to receive either standard care alone or standard care plus albumin for up to 3 days. The main goal is to see if this extra treatment improves the chance of being alive 28 days later.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPTIC SHOCK are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Faculty of Medicine, Siriraj Hospital, Mahidol University
Bangkok, Bangkoknoi, 10700, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.